Retinal Vein Occlusion Therapeutics Market Report

Global and Region Retinal Vein Occlusion Therapeutics Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Aug 01, 2022
  • PAGES：212
  • REPORT CODE：GMM953270
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Retinal Vein Occlusion Therapeutics market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Retinal Vein Occlusion Therapeuticsmarket, defines the market attractiveness level of Retinal Vein Occlusion Therapeutics market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Retinal Vein Occlusion Therapeutics industry, describes the types of Retinal Vein Occlusion Therapeutics market, the applications of major players and the market size, and deeply analyzes the current situation of the global Retinal Vein Occlusion Therapeutics market and the development prospects and opportunities of Retinal Vein Occlusion Therapeutics industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Retinal Vein Occlusion Therapeutics market in Chapter 13.

    By Player:

    • SciFluor Life Sciences LLC

    • ThromboGenics NV

    • Regeneron Pharmaceuticals Inc

    • Novartis AG

    • Formycon AG

    • Graybug Vision Inc

    • Ohr Pharmaceutical Inc

    • Kala Pharmaceuticals Inc

    • Annexin Pharmaceuticals AB

    • Lupin Ltd

    • Mabion SA

    • Clearside BioMedical Inc

    • Acucela Inc

    • Aerpio Therapeutics Inc

    • Ocular Therapeutix Inc

    • Chengdu Kanghong Pharmaceuticals Group Co Ltd

    • Addmedica SAS

    By Type:

    • Aflibercept Biosimilar

    • Aflibercept SR

    • AKB-9778

    • AP-01

    • Others

    By End-User:

    • Research Center

    • Clinic

    • Hospital

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Retinal Vein Occlusion Therapeutics Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Retinal Vein Occlusion Therapeutics Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Retinal Vein Occlusion Therapeutics Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Retinal Vein Occlusion Therapeutics Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Retinal Vein Occlusion Therapeutics Market Analysis and Outlook to 2022

    • 7.1 Global Retinal Vein Occlusion Therapeutics Consumption (2017-2022)

    • 7.2 United States Retinal Vein Occlusion Therapeutics Consumption (2017-2022)

    • 7.3 Europe Retinal Vein Occlusion Therapeutics Consumption (2017-2022)

    • 7.4 China Retinal Vein Occlusion Therapeutics Consumption (2017-2022)

    • 7.5 Japan Retinal Vein Occlusion Therapeutics Consumption (2017-2022)

    • 7.6 India Retinal Vein Occlusion Therapeutics Consumption (2017-2022)

    • 7.7 South Korea Retinal Vein Occlusion Therapeutics Consumption (2017-2022)

    8 Region and Country-wise Retinal Vein Occlusion Therapeutics Market Analysis and Outlook to 2028

    • 8.1 Global Retinal Vein Occlusion Therapeutics Consumption Forecast (2022-2028)

    • 8.2 United States Retinal Vein Occlusion Therapeutics Consumption Forecast (2022-2028)

    • 8.3 Europe Retinal Vein Occlusion Therapeutics Consumption Forecast (2022-2028)

    • 8.4 China Retinal Vein Occlusion Therapeutics Consumption Forecast (2022-2028)

    • 8.5 Japan Retinal Vein Occlusion Therapeutics Consumption Forecast (2022-2028)

    • 8.6 India Retinal Vein Occlusion Therapeutics Consumption Forecast (2022-2028)

    • 8.7 South Korea Retinal Vein Occlusion Therapeutics Consumption Forecast (2022-2028)

    9 Global Retinal Vein Occlusion Therapeutics Market Outlook by Types and Applications to 2022

    • 9.1 Global Retinal Vein Occlusion Therapeutics Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Aflibercept Biosimilar Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Aflibercept SR Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global AKB-9778 Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global AP-01 Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Others Consumption and Growth Rate (2017-2022)

    • 9.2 Global Retinal Vein Occlusion Therapeutics Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Research Center Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Clinic Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Hospital Consumption and Growth Rate (2017-2022)

    10 Global Retinal Vein Occlusion Therapeutics Market Outlook by Types and Applications to 2028

    • 10.1 Global Retinal Vein Occlusion Therapeutics Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Aflibercept Biosimilar Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Aflibercept SR Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global AKB-9778 Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global AP-01 Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.5 Global Others Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Retinal Vein Occlusion Therapeutics Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Research Center Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Clinic Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Hospital Consumption Forecast and Growth Rate (2022-2028)

    11 Global Retinal Vein Occlusion Therapeutics Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Retinal Vein Occlusion Therapeutics Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Retinal Vein Occlusion Therapeutics Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Retinal Vein Occlusion Therapeutics Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Retinal Vein Occlusion Therapeutics Market Competitive Analysis

    • 14.1 SciFluor Life Sciences LLC

      • 14.1.1 SciFluor Life Sciences LLC Company Details

      • 14.1.2 SciFluor Life Sciences LLC Retinal Vein Occlusion Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 SciFluor Life Sciences LLC Retinal Vein Occlusion Therapeutics Product and Service

    • 14.2 ThromboGenics NV

      • 14.2.1 ThromboGenics NV Company Details

      • 14.2.2 ThromboGenics NV Retinal Vein Occlusion Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 ThromboGenics NV Retinal Vein Occlusion Therapeutics Product and Service

    • 14.3 Regeneron Pharmaceuticals Inc

      • 14.3.1 Regeneron Pharmaceuticals Inc Company Details

      • 14.3.2 Regeneron Pharmaceuticals Inc Retinal Vein Occlusion Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Regeneron Pharmaceuticals Inc Retinal Vein Occlusion Therapeutics Product and Service

    • 14.4 Novartis AG

      • 14.4.1 Novartis AG Company Details

      • 14.4.2 Novartis AG Retinal Vein Occlusion Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Novartis AG Retinal Vein Occlusion Therapeutics Product and Service

    • 14.5 Formycon AG

      • 14.5.1 Formycon AG Company Details

      • 14.5.2 Formycon AG Retinal Vein Occlusion Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Formycon AG Retinal Vein Occlusion Therapeutics Product and Service

    • 14.6 Graybug Vision Inc

      • 14.6.1 Graybug Vision Inc Company Details

      • 14.6.2 Graybug Vision Inc Retinal Vein Occlusion Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Graybug Vision Inc Retinal Vein Occlusion Therapeutics Product and Service

    • 14.7 Ohr Pharmaceutical Inc

      • 14.7.1 Ohr Pharmaceutical Inc Company Details

      • 14.7.2 Ohr Pharmaceutical Inc Retinal Vein Occlusion Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Ohr Pharmaceutical Inc Retinal Vein Occlusion Therapeutics Product and Service

    • 14.8 Kala Pharmaceuticals Inc

      • 14.8.1 Kala Pharmaceuticals Inc Company Details

      • 14.8.2 Kala Pharmaceuticals Inc Retinal Vein Occlusion Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Kala Pharmaceuticals Inc Retinal Vein Occlusion Therapeutics Product and Service

    • 14.9 Annexin Pharmaceuticals AB

      • 14.9.1 Annexin Pharmaceuticals AB Company Details

      • 14.9.2 Annexin Pharmaceuticals AB Retinal Vein Occlusion Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Annexin Pharmaceuticals AB Retinal Vein Occlusion Therapeutics Product and Service

    • 14.10 Lupin Ltd

      • 14.10.1 Lupin Ltd Company Details

      • 14.10.2 Lupin Ltd Retinal Vein Occlusion Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Lupin Ltd Retinal Vein Occlusion Therapeutics Product and Service

    • 14.11 Mabion SA

      • 14.11.1 Mabion SA Company Details

      • 14.11.2 Mabion SA Retinal Vein Occlusion Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Mabion SA Retinal Vein Occlusion Therapeutics Product and Service

    • 14.12 Clearside BioMedical Inc

      • 14.12.1 Clearside BioMedical Inc Company Details

      • 14.12.2 Clearside BioMedical Inc Retinal Vein Occlusion Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 Clearside BioMedical Inc Retinal Vein Occlusion Therapeutics Product and Service

    • 14.13 Acucela Inc

      • 14.13.1 Acucela Inc Company Details

      • 14.13.2 Acucela Inc Retinal Vein Occlusion Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.13.3 Acucela Inc Retinal Vein Occlusion Therapeutics Product and Service

    • 14.14 Aerpio Therapeutics Inc

      • 14.14.1 Aerpio Therapeutics Inc Company Details

      • 14.14.2 Aerpio Therapeutics Inc Retinal Vein Occlusion Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.14.3 Aerpio Therapeutics Inc Retinal Vein Occlusion Therapeutics Product and Service

    • 14.15 Ocular Therapeutix Inc

      • 14.15.1 Ocular Therapeutix Inc Company Details

      • 14.15.2 Ocular Therapeutix Inc Retinal Vein Occlusion Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.15.3 Ocular Therapeutix Inc Retinal Vein Occlusion Therapeutics Product and Service

    • 14.16 Chengdu Kanghong Pharmaceuticals Group Co Ltd

      • 14.16.1 Chengdu Kanghong Pharmaceuticals Group Co Ltd Company Details

      • 14.16.2 Chengdu Kanghong Pharmaceuticals Group Co Ltd Retinal Vein Occlusion Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.16.3 Chengdu Kanghong Pharmaceuticals Group Co Ltd Retinal Vein Occlusion Therapeutics Product and Service

    • 14.17 Addmedica SAS

      • 14.17.1 Addmedica SAS Company Details

      • 14.17.2 Addmedica SAS Retinal Vein Occlusion Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.17.3 Addmedica SAS Retinal Vein Occlusion Therapeutics Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Retinal Vein Occlusion Therapeutics

    • Figure Retinal Vein Occlusion Therapeutics Picture

    • Table Global Retinal Vein Occlusion Therapeutics Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Retinal Vein Occlusion Therapeutics Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Retinal Vein Occlusion Therapeutics Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Retinal Vein Occlusion Therapeutics Consumption by Country (2017-2022)

    • Figure United States Retinal Vein Occlusion Therapeutics Consumption and Growth Rate (2017-2022)

    • Table Europe Retinal Vein Occlusion Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure China Retinal Vein Occlusion Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Japan Retinal Vein Occlusion Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure India Retinal Vein Occlusion Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure South Korea Retinal Vein Occlusion Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Global Retinal Vein Occlusion Therapeutics Consumption Forecast by Country (2022-2028)

    • Figure United States Retinal Vein Occlusion Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Retinal Vein Occlusion Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Retinal Vein Occlusion Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Retinal Vein Occlusion Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Retinal Vein Occlusion Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Retinal Vein Occlusion Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Aflibercept Biosimilar Consumption and Growth Rate (2017-2022)

    • Figure Global Aflibercept SR Consumption and Growth Rate (2017-2022)

    • Figure Global AKB-9778 Consumption and Growth Rate (2017-2022)

    • Figure Global AP-01 Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Research Center Consumption and Growth Rate (2017-2022)

    • Figure Global Clinic Consumption and Growth Rate (2017-2022)

    • Figure Global Hospital Consumption and Growth Rate (2017-2022)

    • Figure Global Aflibercept Biosimilar Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Aflibercept SR Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global AKB-9778 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global AP-01 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Research Center Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Clinic Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Retinal Vein Occlusion Therapeutics Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Retinal Vein Occlusion Therapeutics Export by Region (Top 5 Countries) (2017-2028)

    • Table SciFluor Life Sciences LLC (Foundation Year, Company Profile and etc.)

    • Table SciFluor Life Sciences LLC Retinal Vein Occlusion Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table SciFluor Life Sciences LLC Retinal Vein Occlusion Therapeutics Product and Service

    • Table ThromboGenics NV (Foundation Year, Company Profile and etc.)

    • Table ThromboGenics NV Retinal Vein Occlusion Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table ThromboGenics NV Retinal Vein Occlusion Therapeutics Product and Service

    • Table Regeneron Pharmaceuticals Inc (Foundation Year, Company Profile and etc.)

    • Table Regeneron Pharmaceuticals Inc Retinal Vein Occlusion Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Regeneron Pharmaceuticals Inc Retinal Vein Occlusion Therapeutics Product and Service

    • Table Novartis AG (Foundation Year, Company Profile and etc.)

    • Table Novartis AG Retinal Vein Occlusion Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis AG Retinal Vein Occlusion Therapeutics Product and Service

    • Table Formycon AG (Foundation Year, Company Profile and etc.)

    • Table Formycon AG Retinal Vein Occlusion Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Formycon AG Retinal Vein Occlusion Therapeutics Product and Service

    • Table Graybug Vision Inc (Foundation Year, Company Profile and etc.)

    • Table Graybug Vision Inc Retinal Vein Occlusion Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Graybug Vision Inc Retinal Vein Occlusion Therapeutics Product and Service

    • Table Ohr Pharmaceutical Inc (Foundation Year, Company Profile and etc.)

    • Table Ohr Pharmaceutical Inc Retinal Vein Occlusion Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Ohr Pharmaceutical Inc Retinal Vein Occlusion Therapeutics Product and Service

    • Table Kala Pharmaceuticals Inc (Foundation Year, Company Profile and etc.)

    • Table Kala Pharmaceuticals Inc Retinal Vein Occlusion Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Kala Pharmaceuticals Inc Retinal Vein Occlusion Therapeutics Product and Service

    • Table Annexin Pharmaceuticals AB (Foundation Year, Company Profile and etc.)

    • Table Annexin Pharmaceuticals AB Retinal Vein Occlusion Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Annexin Pharmaceuticals AB Retinal Vein Occlusion Therapeutics Product and Service

    • Table Lupin Ltd (Foundation Year, Company Profile and etc.)

    • Table Lupin Ltd Retinal Vein Occlusion Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Lupin Ltd Retinal Vein Occlusion Therapeutics Product and Service

    • Table Mabion SA (Foundation Year, Company Profile and etc.)

    • Table Mabion SA Retinal Vein Occlusion Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Mabion SA Retinal Vein Occlusion Therapeutics Product and Service

    • Table Clearside BioMedical Inc (Foundation Year, Company Profile and etc.)

    • Table Clearside BioMedical Inc Retinal Vein Occlusion Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Clearside BioMedical Inc Retinal Vein Occlusion Therapeutics Product and Service

    • Table Acucela Inc (Foundation Year, Company Profile and etc.)

    • Table Acucela Inc Retinal Vein Occlusion Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Acucela Inc Retinal Vein Occlusion Therapeutics Product and Service

    • Table Aerpio Therapeutics Inc (Foundation Year, Company Profile and etc.)

    • Table Aerpio Therapeutics Inc Retinal Vein Occlusion Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Aerpio Therapeutics Inc Retinal Vein Occlusion Therapeutics Product and Service

    • Table Ocular Therapeutix Inc (Foundation Year, Company Profile and etc.)

    • Table Ocular Therapeutix Inc Retinal Vein Occlusion Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Ocular Therapeutix Inc Retinal Vein Occlusion Therapeutics Product and Service

    • Table Chengdu Kanghong Pharmaceuticals Group Co Ltd (Foundation Year, Company Profile and etc.)

    • Table Chengdu Kanghong Pharmaceuticals Group Co Ltd Retinal Vein Occlusion Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Chengdu Kanghong Pharmaceuticals Group Co Ltd Retinal Vein Occlusion Therapeutics Product and Service

    • Table Addmedica SAS (Foundation Year, Company Profile and etc.)

    • Table Addmedica SAS Retinal Vein Occlusion Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Addmedica SAS Retinal Vein Occlusion Therapeutics Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US